Therapeutic Treatment for Benign Prostatic Hyperplasia
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to va…
Mehr
CHF 81.25
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
- ISBN: 978-0-203-08805-0
- EAN: 9780203088050
- Produktnummer: 18393598
- Verlag: Crc Press
- Sprache: Englisch
- Erscheinungsjahr: 2005
- Seitenangabe: 210 S.
- Plattform: PDF
- Masse: 0 KB
5 weitere Werke von Peter (Hrsg.) Boyle:
Bewertungen
Anmelden